143 related articles for article (PubMed ID: 15860541)
1. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.
Griol-Charhbili V; Messadi-Laribi E; Bascands JL; Heudes D; Meneton P; Giudicelli JF; Alhenc-Gelas F; Richer C
FASEB J; 2005 Jul; 19(9):1172-4. PubMed ID: 15860541
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
[TBL] [Abstract][Full Text] [Related]
3. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
4. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
5. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
Lange SA; Wolf B; Schober K; Wunderlich C; Marquetant R; Weinbrenner C; Strasser RH
J Cardiovasc Pharmacol; 2007 Jan; 49(1):46-55. PubMed ID: 17261963
[TBL] [Abstract][Full Text] [Related]
6. Tissue kallikrein-deficient mice display a defect in renal tubular calcium absorption.
Picard N; Van Abel M; Campone C; Seiler M; Bloch-Faure M; Hoenderop JG; Loffing J; Meneton P; Bindels RJ; Paillard M; Alhenc-Gelas F; Houillier P
J Am Soc Nephrol; 2005 Dec; 16(12):3602-10. PubMed ID: 16251243
[TBL] [Abstract][Full Text] [Related]
7. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
8. Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes.
Potier L; Waeckel L; Vincent MP; Chollet C; Gobeil F; Marre M; Bruneval P; Richer C; Roussel R; Alhenc-Gelas F; Bouby N
J Pharmacol Exp Ther; 2013 Jul; 346(1):23-30. PubMed ID: 23591995
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
10. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
Gröger M; Lebesgue D; Pruneau D; Relton J; Kim SW; Nussberger J; Plesnila N
J Cereb Blood Flow Metab; 2005 Aug; 25(8):978-89. PubMed ID: 15815587
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
Freise H; Palmes D; Spiegel HU
J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
[TBL] [Abstract][Full Text] [Related]
12. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
[TBL] [Abstract][Full Text] [Related]
13. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
14. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
Schriefer JA; Broudy EP; Hassen AH
J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
[TBL] [Abstract][Full Text] [Related]
16. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart.
Sanchez de Miguel L; Neysari S; Jakob S; Petrimpol M; Butz N; Banfi A; Zaugg CE; Humar R; Battegay EJ
Cardiovasc Res; 2008 Oct; 80(1):106-13. PubMed ID: 18566101
[TBL] [Abstract][Full Text] [Related]
17. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
[TBL] [Abstract][Full Text] [Related]
19. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors.
Martorana PA; Schölkens BA
Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888
[TBL] [Abstract][Full Text] [Related]
20. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats.
Yang XP; Liu YH; Scicli GM; Webb CR; Carretero OA
Hypertension; 1997 Sep; 30(3 Pt 2):735-40. PubMed ID: 9323015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
